Article Information
History
- May 21, 2020.
Article Versions
- Version 1 (May 15, 2020 - 16:40).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rumi Ueha, M.D., Ph.D.1,*,
- Kenji Kondo, M.D., Ph.D.1,
- Ryoji Kagoya, M.D., Ph.D.1,
- Shigeyuki Shichino, Ph.D.2,
- Satoshi Ueha, Ph.D.2 and
- Tatsuya Yamasoba, M.D., Ph.D.
- 1Department of Otolaryngology and Head and Neck Surgery, Faculty of Medicine, the University of Tokyo, Tokyo, Japan
- 2Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan
- ↵*Correspondence to: Rumi Ueha, Department of Otolaryngology and Head and Neck Surgery, Faculty of Medicine, the University of Tokyo, Tokyo, Japan, 113-8655, E-mail: ruu1025{at}yahoo.co.jp, Tel: +81-3-3815-5411, Fax: +81-3-3814-9486
Posted May 21, 2020.
Understanding olfactory dysfunction in COVID-19: Expression of ACE2, TMPRSS2 and Furin in the nose and olfactory bulb in human and mice
